Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia

British Journal of Anaesthesia

Volumn 99, Issue 4, 2007, Pages 538-546

  Iwata, M ^a   Inoue, Sen ^a   Kawaguchi, M ^a   Nakamura, M ^a   Konishi, N ^a   Furuya, H ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Analgesics opioid, DADLE; Analgesics opioid, delta opioid; Antagonists opioid, nattrindole; Brain, hippocampus, neuroprotection; Brain, ischaemis, forebrain ischaemia

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ISOFLURANE; NALTRINDOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CLINICAL EVALUATION; CONTROLLED STUDY; DENTATE GYRUS; DISEASE SEVERITY; DRUG EFFICACY; FOREBRAIN; HIPPOCAMPUS; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SURVIVAL;

EID: 34548677734     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem220     Document Type: Article

References (41)

1. Su TP. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin promotes cell survival. J Biomed Sci 2000; 7: 195-9
2. Zhang JH, Haddad GG, Xia Y. Delt-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res 2000; 885: 143-53
3. Zhang J, Gibney GT, Zhao P, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol 2002; 282: C1225-34
4. Horiuchi T, Kawaguchi M, Sakamoto T, et al. The effects of the delta-opioid agonist SNC80 on hind-limb motor function and neuronal injury after spinal cord ischemia in rats. Anesth Analg 2004; 99: 235-40
5. Tsao LI, Ladenheim B, Andrews AM, Chiueh CC, Cadet JL, Su TP. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin blocks the long-term loss of dopamine transporter induced by multiple administration of methamphetamine: Involvement of opioid receptors and reactive oxygen species. J Pharmacol Exp Ther 1998; 287: 322-31
6. Borlongan CV, Su TP, Wang Y. Treatment of delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 2000; 11: 923-6.
7. Kastin AJ, Nissen C, Schally AV, Coy DH. Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Res Bull 1976; 1: 583-9
8. 5]enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia. Neurosci Lett 2007; 414: 242-6
9. Baker AK, Meert TF. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J Pharmacol Exp Ther 2002; 302: 1253-64
10. Sano T, Patel PM, Drummond JC, Cole DJ. A comparison of the cerebral protective effects of etomidate, thiopental, and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg 1993; 76: 990-7
11. Palkovis M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. New York, NY: Elsevier, 1980
12. Hayashi T, Tsao LI, Su TP. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala2, D-Leu5]enkephalin in PC12 cells. Synapse 2002; 43: 86-94
13. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43: 1369-74
14. Drejer J, Benveniste H, Diemer NH, Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 1985; 45: 145-51
15. Baker AJ, Zornow MH, Scheller MS, et al. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J Neurochem 1991; 57: 1370-9
16. Kawaguchi M, Kimbro JR, Drummond JC, Cole DJ, Kelly PJ, Patel PM. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 2000; 92: 1335-42
17. Inoue S, Drummond JC, Davis DP, Cole DJ, Patel PM. Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia. Anesthesiology 2004; 101 75-81
18. Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology 2004; 100: 1160-6
19. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 2004; 100: 562-8
20. Zhao P, Huang Y, Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 2006; 65: 945-52
21. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989; 20: 1627-42
22. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ. Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels. Circ Res 1999; 84: 846-51
23. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta 1- but not mu- or kappa-opioid receptors. Circulation 1998; 97: 1282-9
24. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: From adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62: 79-109
25. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186: 3-12
26. Acosta CG, Lopez HS. Delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons. J Neurosci 1999; 19: 8337-48
27. Cahill CM, McClellan KA, Morinville A, et al. Immunohisto-chemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 2001; 440: 65-84
28. Tempel A, Zukin RS. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci USA 1987; 84: 4308-12
29. Goodman RR, Snyder SH, Kuhar MJ, Young WS, 3rd. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci USA 1980; 77: 6239-43
30. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 1987; 7: 2445-64
31. Commons KG, Milner TA. Cellular and subcellular localization of delta opioid receptor immunoreactivity in the rat dentate gyrus. Brain Res 1996; 738: 181-95
32. McLean S, Rothman RB, Herkenham M. Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat. Brain Res 1986; 378: 49-60
33. George SR, Zastawny RL, Briones-Urbina R, et al. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 1994; 205: 1438-44
34. Pasternak GW. High and low affinity opioid binding sites: Relationship to mu and delta sites. Life Sci 1982; 31: 1303-6
35. Mansour A, Thompson RC, Akil H, Watson SJ. Delta opioid receptor mRNA distribution in the brain: Comparison to delta receptor binding and proenkephalin mRNA. J Chem Neuroanat 1993; 6: 351-62
36. Fried RL, Nowak TS, Jr. Opioid peptide levels in gerbil brain after transient ischemia: Lasting depletion of hippocampal dynorphin. Stroke 1987; 18: 765-70
37. Collier TJ, Quirk GJ, Routtenberg A. Separable roles of hippocampal granule cells in forgetting and pyramidal cells in remembering spatial information. Brain Res 1987; 409: 316-28
38. Gallagher M. Behavioral significance of opioid peptides in relation to hippocampal function. NIDA Res Monogr 1988; 82: 118-32
39. Chen W, Yang JZ, Andersen R, Nielsen LH, Borchardt RT. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. J Pharmacol Exp Ther 2002; 303: 849-57
40. 2O. Anesthesiology 1988; 69: 192-8
41. Miura Y, Grocott HP, Bart RD, Pearlstein RD, Dexter F, Warner DS. Differential effects of anesthetic agents on outcome from near-complete but not incomplete global ischemia in the rat. Anesthesiology 1998; 89: 391-400